Despite major advances in targeted therapies, many cancer patients either lack access to biomarker testing or face life-threatening testing delays. Acurion aims to expand access to precision oncology ...
TNO and Orikami are accelerating the deployment of digital biomarkers by combining scientific validation with a scalable, ...
We reveal health patterns of daily life through patient-centric digital biomarkers – accelerating personalised healthcare and ...
Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...
The study showed statistically significant improvements (p<0.05) across 43 biomarkers, including LDL cholesterol, HbA1c, and vitamin D, in a cohort of over 20,000 users. -- Proven Engagement and ...
Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non–Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score Retrospective RWD ...
Faculty in the Medical Devices and Diagnostics Hub develop statistical methods for the design, evaluation, and validation of diagnostic tools and medical devices. Their work includes biomarker ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
BACKGROUND: With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results